Offer Products
Face Care
Hair Care
stationery & office
Tea & Coffee
Baby Wipes
Cream
Baby Essentials
Fragrances
Lip Care
Body Care
Air Freshener
Product Benefits
| Core Benefit | Mechanism |
| Synergistic Efficacy | Combines two agents targeting different mechanisms: boosting glucose-dependent insulin release (Vildagliptin) and improving the body's response to insulin (Metformin), resulting in enhanced $\text{A1c}$ lowering. |
| Dose Titration Potential | The $500\text{ mg}$ Metformin component is suitable for patients starting combination therapy, allowing for gradual titration to minimize gastrointestinal side effects commonly associated with Metformin. |
| Convenient Single-Tablet Dosing | Consolidating both medications into one tablet improves patient adherence compared to taking two separate pills. |
| Low Hypoglycemia Risk | Both active ingredients carry a low inherent risk of causing hypoglycemia when used without insulin or sulfonylureas. |
⚠️ Important Safety Note: Combination Diabetes Tablet
Black Box Warning (Lactic Acidosis): Metformin carries a Black Box Warning for the rare but serious risk of lactic acidosis, especially in patients with kidney impairment.
11 Kidney function must be monitored regularly.Pancreatitis Risk: Vildagliptin has been associated with reports of acute pancreatitis.
12 Seek medical attention immediately if you develop severe, persistent abdominal pain.Prescription Required: This medication must be used strictly as prescribed and combined with diet and exercise.
Warning! You must be logged in to submit a review.
Login
Customer questions & answers
Customer reviews
0 out of 5